Breaking News
Sort by:
Top Post
GSK Announces £1 Billion R&D Investment Over Ten Years to Get Ahead of Infectious Diseases in Lower-income Countries
GSK plc (LSE/NYSE: GSK) announced today an investment of £1bn over ten years to accelerate […]
Patients to Have Earlier Access to Cutting-edge Treatments on NHS
NHS patients in England will have early access to potentially life-saving and cutting-edge treatments thanks […]
Obesity Linked to Damaging Changes in Failing Hearts
Obesity is linked to changes in the structure and pumping action of the heart before […]
Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth
Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, today announced the […]
One Million Checks Delivered By NHS ‘One Stop Shops’
NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]
Tobias Hauser Joins Limbic to Help Close UK Demand-supply Gap of Psychological Therapy
Tobias Hauser, joins Limbic as its Head of Computational Psychiatry. Hauser has worked at the […]
Medtronic and DaVita Announce New Kidney Health Technology Company
Medtronic plc (NYSE:MDT) and DaVita Inc. (NYSE:DVA) today announced the intent to form a new, independent kidney care-focused […]
PharmEnable Announces Multi-target Collaboration With Denali Therapeutics in Neurodegenerative Disease
PharmEnable, an AI drug-discovery company mapping unexplored chemical space to deliver innovative medicines, has announced […]
Frozen Eggs More Efficient Option than IVF for Women Starting Families Later
The largest U.S. report of elective fertility preservation outcomes to date found that 70 percent […]
New £12.7M Centre of Excellence in Emerging Digital Technologies Officially Opens
The University of Liverpool’s Digital Innovation Facility (DIF), a £12.7 million Centre of Excellence in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more